SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/06/22 American Resources Corp. 8-K:1,7,9 8/30/22 14:605K Blueprint/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 28K 2: EX-10.1 Material Contract HTML 6K 3: EX-99.1 Miscellaneous Exhibit HTML 19K 9: R1 Cover HTML 42K 12: XML IDEA XML File -- Filing Summary XML 13K 10: XML XBRL Instance -- arec_8k_htm XML 15K 11: EXCEL IDEA Workbook of Financial Reports XLSX 8K 6: EX-101.CAL XBRL Calculations -- arec-20220830_cal XML 8K 8: EX-101.DEF XBRL Definitions -- arec-20220830_def XML 11K 5: EX-101.LAB XBRL Labels -- arec-20220830_lab XML 41K 7: EX-101.PRE XBRL Presentations -- arec-20220830_pre XML 28K 4: EX-101.SCH XBRL Schema -- arec-20220830 XSD 19K 13: JSON XBRL Instance as JSON Data -- MetaLinks 11± 16K 14: ZIP XBRL Zipped Folder -- 0001654954-22-012192-xbrl Zip 21K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest event Reported): i August 30, 2022
(Exact name of registrant as specified in its charter) |
i Florida |
|
| i 46-3914127 | |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (I.R.S. Employer Identification No.) |
i 12115 Visionary Way, i Suite 174, i Fishers i Indiana, i 46038
(Address of principal executive offices)
( i 606) i 637-3740
(Registrant’s telephone number, including area code)
_____________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See: General Instruction A.2. below):
i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR240.14a-12)
i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On August 30, 2022, American Resources Corporation (“American Resources” or the “Company”) entered into an asset sale and new leadership agreement (collectively the “Agreement”) with Novusterra Inc. (“Novusterra”) related to certain patents and technologies held by American Resources related to the development, production and commercialization of graphene and carbon nanostructures (the “Graphene Technologies”). Pursuant to the Agreement, American Resources will:
| 1. | Sell the exclusive rights to the Graphene Technologies held by American Resources Corporation to Novusterra Inc. for 4.0 million shares valued at $4.00 per share; |
|
|
|
| 2. | Andrew Weeraratne will step down from the board and as an officer of Novusterra. Dr. Greg Jensen will be named CEO and Director. Dr. Gerardine Botte will be named Chief Technology Officer and Mark LaVerghetta will be named Chairman of the Company, Mark Jensen will step down as Chairman; and |
|
|
|
| 3. | Novusterra Inc. will issue: |
|
|
|
| a. | Dr. Gregory Jensen: 1.1 million. |
| b. | Dr. Gerardine Botte to join as the CTO: 1.0 million. |
| c. | Jeff Peterson as Vice President of Operations: 350,000. |
| d. | Tarlis Thompson as Vice President of Operations: 100,000. |
| e. | Christian Alvarez Pugliese as Vice President of Research: 150,000. |
| f. | David Sauve as Vice President of Marketing: 50,000. |
The Novusterra shares issued are not registered and will not be registered in connection with the Agreement under the Securities Act of 1933, as amended (the “Securities Act”), or any state’s securities laws, on the grounds that the transaction in which the shares are to be issued qualifies for applicable exemptions from the securities registration requirements of such statutes. The exemptions being claimed include, but are not necessarily limited to, those available under Section 4(a)(2) of the Securities Act and the reliance by Novusterra upon the exemptions from the securities registration requirements of the federal and state securities laws, is predicated in part on the representations, understandings and covenants set forth in the Agreements.
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement between American Resources and Novusterra which is attached as Exhibit 10.1 to this Current Report and incorporated by reference herein.
Item 7.01. Regulation FD Disclosure
On August 31, 2022, American Resources Corporation (or the “Company”) issued a press release announcing the sale of the exclusive patent rights of its carbon nanostructure and graphene technology to Novusterra Inc. for $16 million paid in all Class A common Novusterra shares.
The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.
A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
2 |
Item 9.01 Financial Statements and Exhibits.
(d) | Exhibits |
The following exhibits are attached hereto and filed herewith.
Exhibit No. | Description | |
Agreement between American Resources Corporation and Novusterra Inc. | ||
|
3 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
American Resources Corporation | |||
Date: September 6, 2022 | By: | /s/ Mark C. Jensen | |
|
| Mark C. Jensen | |
Chief Executive Officer |
4 |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 9/6/22 | None on these Dates | ||
8/31/22 | ||||
For Period end: | 8/30/22 | |||
List all Filings |